

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.36611081 |
| 2 | keratinization (GO:0031424) | 5.15440087 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.86126174 |
| 4 | establishment of skin barrier (GO:0061436) | 4.54700115 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.48728121 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.48728121 |
| 7 | regulation of cell communication by electrical coupling (GO:0010649) | 4.38006405 |
| 8 | prepulse inhibition (GO:0060134) | 4.34672078 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.31305084 |
| 10 | histone H4-K8 acetylation (GO:0043982) | 4.27486669 |
| 11 | histone H4-K5 acetylation (GO:0043981) | 4.27486669 |
| 12 | response to histamine (GO:0034776) | 4.17258124 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.99064147 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.96611093 |
| 15 | gamma-aminobutyric acid transport (GO:0015812) | 3.95655456 |
| 16 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.94373634 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.91737297 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 3.90587961 |
| 19 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.87552775 |
| 20 | regulation of relaxation of muscle (GO:1901077) | 3.87478042 |
| 21 | regulation of water loss via skin (GO:0033561) | 3.86169252 |
| 22 | histone H4-K16 acetylation (GO:0043984) | 3.85493031 |
| 23 | locomotory exploration behavior (GO:0035641) | 3.82339282 |
| 24 | activated T cell proliferation (GO:0050798) | 3.82133127 |
| 25 | neurotransmitter uptake (GO:0001504) | 3.81675439 |
| 26 | auditory behavior (GO:0031223) | 3.80901456 |
| 27 | cAMP-mediated signaling (GO:0019933) | 3.75969794 |
| 28 | desmosome organization (GO:0002934) | 3.74077282 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.70865896 |
| 30 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.70203171 |
| 31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.69783171 |
| 32 | neurotransmitter transport (GO:0006836) | 3.63771927 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.63344022 |
| 34 | T cell selection (GO:0045058) | 3.59889015 |
| 35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.55814139 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.55407187 |
| 37 | cellular response to epinephrine stimulus (GO:0071872) | 3.53768041 |
| 38 | synaptic transmission, dopaminergic (GO:0001963) | 3.53168065 |
| 39 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.49649608 |
| 40 | regulation of neurotransmitter levels (GO:0001505) | 3.46928234 |
| 41 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.45930050 |
| 42 | drinking behavior (GO:0042756) | 3.45495424 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43830252 |
| 44 | phosphorelay signal transduction system (GO:0000160) | 3.43010752 |
| 45 | tachykinin receptor signaling pathway (GO:0007217) | 3.42814265 |
| 46 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.41653752 |
| 47 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.41653752 |
| 48 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.37305653 |
| 49 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.37235754 |
| 50 | synaptic vesicle maturation (GO:0016188) | 3.37099664 |
| 51 | positive T cell selection (GO:0043368) | 3.34589927 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 3.33472404 |
| 53 | cAMP catabolic process (GO:0006198) | 3.32381073 |
| 54 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.29660915 |
| 55 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.28703551 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.28357348 |
| 57 | cellular potassium ion homeostasis (GO:0030007) | 3.27391860 |
| 58 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.25569321 |
| 59 | regulation of postsynaptic membrane potential (GO:0060078) | 3.23906898 |
| 60 | striatum development (GO:0021756) | 3.21549913 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.21469330 |
| 62 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.19425438 |
| 63 | regulation of synapse structural plasticity (GO:0051823) | 3.16743564 |
| 64 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.16595295 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16417230 |
| 66 | negative regulation of microtubule polymerization (GO:0031115) | 3.14477465 |
| 67 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13755873 |
| 68 | negative regulation of stress fiber assembly (GO:0051497) | 3.09622834 |
| 69 | dopamine receptor signaling pathway (GO:0007212) | 3.09063719 |
| 70 | cellular response to monoamine stimulus (GO:0071868) | 3.08778766 |
| 71 | cellular response to catecholamine stimulus (GO:0071870) | 3.08778766 |
| 72 | negative regulation of heart contraction (GO:0045822) | 3.07990425 |
| 73 | vesicle transport along microtubule (GO:0047496) | 3.07395470 |
| 74 | mechanosensory behavior (GO:0007638) | 3.07114215 |
| 75 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.06733251 |
| 76 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.06652476 |
| 77 | behavioral response to cocaine (GO:0048148) | 3.03800617 |
| 78 | vocalization behavior (GO:0071625) | 3.02964932 |
| 79 | cyclic nucleotide catabolic process (GO:0009214) | 3.01993511 |
| 80 | regulation of synaptic vesicle transport (GO:1902803) | 3.00114413 |
| 81 | postsynaptic membrane organization (GO:0001941) | 2.99051539 |
| 82 | thymic T cell selection (GO:0045061) | 2.97821777 |
| 83 | L-amino acid import (GO:0043092) | 2.96475443 |
| 84 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.96234389 |
| 85 | positive thymic T cell selection (GO:0045059) | 2.95721714 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95391655 |
| 87 | serine transport (GO:0032329) | 2.95098305 |
| 88 | activation of protein kinase A activity (GO:0034199) | 2.94324488 |
| 89 | neurotransmitter secretion (GO:0007269) | 2.94075754 |
| 90 | DNA deamination (GO:0045006) | 2.93790890 |
| 91 | protein localization to synapse (GO:0035418) | 2.93244174 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93107275 |
| 93 | startle response (GO:0001964) | 2.92448507 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 2.91260314 |
| 95 | L-serine transport (GO:0015825) | 2.91192947 |
| 96 | positive regulation of B cell differentiation (GO:0045579) | 2.90570161 |
| 97 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.90056064 |
| 98 | cerebellar granule cell differentiation (GO:0021707) | 2.89513584 |
| 99 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.89282252 |
| 100 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.87763293 |
| 101 | negative regulation of amino acid transport (GO:0051956) | 2.87554208 |
| 102 | neuron-neuron synaptic transmission (GO:0007270) | 2.87513169 |
| 103 | sodium ion export (GO:0071436) | 2.87186748 |
| 104 | regulation of glutamate secretion (GO:0014048) | 2.86812455 |
| 105 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86352033 |
| 106 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.84918373 |
| 107 | long-term synaptic potentiation (GO:0060291) | 2.84022657 |
| 108 | neuron cell-cell adhesion (GO:0007158) | 2.81524754 |
| 109 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.81234725 |
| 110 | negative T cell selection (GO:0043383) | 2.80695552 |
| 111 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.80603208 |
| 112 | positive regulation of catecholamine secretion (GO:0033605) | 2.79684336 |
| 113 | glycerophospholipid catabolic process (GO:0046475) | 2.79611236 |
| 114 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.79583872 |
| 115 | clathrin coat assembly (GO:0048268) | 2.79527672 |
| 116 | adaptation of signaling pathway (GO:0023058) | 2.79225744 |
| 117 | membrane depolarization (GO:0051899) | 2.78628976 |
| 118 | positive regulation of neurotransmitter transport (GO:0051590) | 2.77937950 |
| 119 | regulation of female receptivity (GO:0045924) | 2.77420274 |
| 120 | glutamate secretion (GO:0014047) | 2.77149905 |
| 121 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76407805 |
| 122 | negative regulation of adaptive immune response (GO:0002820) | 2.75643107 |
| 123 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.75572137 |
| 124 | cellular response to interleukin-15 (GO:0071350) | 2.75521616 |
| 125 | V(D)J recombination (GO:0033151) | 2.75285000 |
| 126 | response to epinephrine (GO:0071871) | 2.74177044 |
| 127 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.73753710 |
| 128 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.73147880 |
| 129 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.72821373 |
| 130 | negative thymic T cell selection (GO:0045060) | 2.72699131 |
| 131 | serotonin metabolic process (GO:0042428) | 2.72213201 |
| 132 | response to auditory stimulus (GO:0010996) | 2.71763876 |
| 133 | keratinocyte differentiation (GO:0030216) | 2.71710470 |
| 134 | regulation of interleukin-5 production (GO:0032674) | 2.71520471 |
| 135 | regulation of neurotransmitter uptake (GO:0051580) | 2.70521125 |
| 136 | glutamate receptor signaling pathway (GO:0007215) | 2.69818534 |
| 137 | exploration behavior (GO:0035640) | 2.69491658 |
| 138 | regulation of synaptic plasticity (GO:0048167) | 2.69461606 |
| 139 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69322964 |
| 140 | histone H3-K36 demethylation (GO:0070544) | 2.69307658 |
| 141 | synaptic transmission (GO:0007268) | 2.67846460 |
| 142 | social behavior (GO:0035176) | 2.65678431 |
| 143 | intraspecies interaction between organisms (GO:0051703) | 2.65678431 |
| 144 | female mating behavior (GO:0060180) | 2.64031542 |
| 145 | presynaptic membrane assembly (GO:0097105) | 2.63969688 |
| 146 | regulation of ARF protein signal transduction (GO:0032012) | 2.63938969 |
| 147 | layer formation in cerebral cortex (GO:0021819) | 2.63915661 |
| 148 | leukocyte aggregation (GO:0070486) | 2.62787693 |
| 149 | synaptic transmission, glutamatergic (GO:0035249) | 2.58341190 |
| 150 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.54730183 |
| 151 | response to interleukin-15 (GO:0070672) | 2.54542748 |
| 152 | G-protein coupled receptor internalization (GO:0002031) | 2.53674462 |
| 153 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.53222618 |
| 154 | positive regulation of membrane potential (GO:0045838) | 2.50368230 |
| 155 | long-term memory (GO:0007616) | 2.50083431 |
| 156 | multicellular organismal water homeostasis (GO:0050891) | 2.49616927 |
| 157 | dendritic spine morphogenesis (GO:0060997) | 2.48830820 |
| 158 | proline transport (GO:0015824) | 2.48643684 |
| 159 | regulation of vesicle fusion (GO:0031338) | 2.47013127 |
| 160 | positive regulation of synaptic transmission (GO:0050806) | 2.46344843 |
| 161 | vesicle targeting (GO:0006903) | 2.44948924 |
| 162 | tolerance induction (GO:0002507) | 2.44043634 |
| 163 | visual learning (GO:0008542) | 2.43939087 |
| 164 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.43865204 |
| 165 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.43601367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.21089747 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.19477931 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.52754518 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.51599295 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.35554996 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.25956843 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.99823066 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.74363513 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.38219989 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.36668616 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26938245 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09992585 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.07728610 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.05527376 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03487077 |
| 16 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.98891781 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.93578149 |
| 18 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.88742801 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84860516 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.83981323 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83792656 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.83218010 |
| 23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81665739 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.79510444 |
| 25 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79378600 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.78754303 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.78039525 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73513580 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73451611 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.67234345 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.67006080 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.66019765 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62775805 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60599462 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60529566 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60266462 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57739067 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55882456 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54922577 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54874226 |
| 41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.50652257 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47371368 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.46008235 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.46008235 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.45474376 |
| 46 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45260432 |
| 47 | RXR_22108803_ChIP-Seq_LS180_Human | 1.44113551 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.41226727 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40133015 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36204680 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33659489 |
| 52 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32942149 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32783408 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31518361 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31368249 |
| 56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29838136 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28766050 |
| 58 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.27773496 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26428607 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25557083 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25084944 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23992211 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22752103 |
| 64 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22209392 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20624120 |
| 66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20449694 |
| 67 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20324996 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19850624 |
| 69 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19040652 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.18695500 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15230345 |
| 72 | MAF_26560356_Chip-Seq_TH1_Human | 1.14677245 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14549361 |
| 74 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13306906 |
| 75 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12079692 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11948537 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10977347 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10747535 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10656953 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10656953 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09681594 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08205229 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.08086891 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07166859 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06310983 |
| 86 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05731140 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05626312 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05430828 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04244735 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04104130 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03771159 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03051841 |
| 93 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02870818 |
| 94 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.02742500 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02513608 |
| 96 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01889581 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00622730 |
| 98 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00322883 |
| 99 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99599519 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99365344 |
| 101 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98522349 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98369273 |
| 103 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97100763 |
| 104 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96343053 |
| 105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96327731 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96148570 |
| 107 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95564811 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95548352 |
| 109 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95419997 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94131012 |
| 111 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93917955 |
| 112 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93677222 |
| 113 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.93581331 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92934757 |
| 115 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92512701 |
| 116 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91821789 |
| 117 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.90917157 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89156817 |
| 119 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88663630 |
| 120 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.87679449 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87174523 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87173250 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87034779 |
| 124 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86490636 |
| 125 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85995785 |
| 126 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85742599 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85733330 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85567441 |
| 129 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84437565 |
| 130 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84020317 |
| 131 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.83763075 |
| 132 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83680499 |
| 133 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83579159 |
| 134 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83366380 |
| 135 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82817406 |
| 136 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82292245 |
| 137 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82087394 |
| 138 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82013583 |
| 139 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82013583 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81687951 |
| 141 | MYB_26560356_Chip-Seq_TH1_Human | 0.80836569 |
| 142 | AR_19668381_ChIP-Seq_PC3_Human | 0.80205163 |
| 143 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.80057767 |
| 144 | STAT3_23295773_ChIP-Seq_U87_Human | 0.79647330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.17191986 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.94655124 |
| 3 | MP0002796_impaired_skin_barrier | 3.84582109 |
| 4 | MP0001968_abnormal_touch/_nociception | 2.95347835 |
| 5 | MP0003880_abnormal_central_pattern | 2.75700785 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.66448882 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 2.65205263 |
| 8 | MP0005451_abnormal_body_composition | 2.61773457 |
| 9 | MP0009745_abnormal_behavioral_response | 2.46708286 |
| 10 | MP0005501_abnormal_skin_physiology | 2.39698218 |
| 11 | MP0003787_abnormal_imprinting | 2.33439215 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.33195439 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.29249789 |
| 14 | MP0002736_abnormal_nociception_after | 2.20377785 |
| 15 | MP0004947_skin_inflammation | 2.19218015 |
| 16 | MP0003303_peritoneal_inflammation | 2.14472043 |
| 17 | MP0002064_seizures | 2.03636180 |
| 18 | MP0009046_muscle_twitch | 2.02600217 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.02252351 |
| 20 | MP0005423_abnormal_somatic_nervous | 1.98021252 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 1.97667687 |
| 22 | MP0005275_abnormal_skin_tensile | 1.96675122 |
| 23 | MP0001800_abnormal_humoral_immune | 1.96420826 |
| 24 | MP0008961_abnormal_basal_metabolism | 1.90210975 |
| 25 | MP0004742_abnormal_vestibular_system | 1.87372555 |
| 26 | MP0003122_maternal_imprinting | 1.83501450 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.82738119 |
| 28 | MP0010771_integument_phenotype | 1.78665658 |
| 29 | MP0005387_immune_system_phenotype | 1.75220075 |
| 30 | MP0001790_abnormal_immune_system | 1.75220075 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.69018872 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.67863244 |
| 33 | MP0000685_abnormal_immune_system | 1.61189995 |
| 34 | MP0001216_abnormal_epidermal_layer | 1.55646219 |
| 35 | MP0002254_reproductive_system_inflammat | 1.50185696 |
| 36 | MP0004142_abnormal_muscle_tone | 1.48820716 |
| 37 | MP0001529_abnormal_vocalization | 1.47146201 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.45591684 |
| 39 | MP0001984_abnormal_olfaction | 1.43970088 |
| 40 | MP0008569_lethality_at_weaning | 1.43795335 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.43245210 |
| 42 | MP0004270_analgesia | 1.42506882 |
| 43 | MP0003633_abnormal_nervous_system | 1.41265486 |
| 44 | MP0002822_catalepsy | 1.39813411 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.38602108 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.38085193 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.37574629 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.37368384 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.33876483 |
| 50 | MP0008995_early_reproductive_senescence | 1.33737654 |
| 51 | MP0001486_abnormal_startle_reflex | 1.33238748 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.32548107 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.32217194 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.29070153 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.28952076 |
| 56 | MP0003121_genomic_imprinting | 1.27998429 |
| 57 | MP0004924_abnormal_behavior | 1.27442080 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.27442080 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.27155851 |
| 60 | MP0010678_abnormal_skin_adnexa | 1.26738670 |
| 61 | MP0000427_abnormal_hair_cycle | 1.26715079 |
| 62 | MP0002723_abnormal_immune_serum | 1.26613520 |
| 63 | MP0002272_abnormal_nervous_system | 1.25396311 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.24741733 |
| 65 | MP0002006_tumorigenesis | 1.23958937 |
| 66 | MP0001970_abnormal_pain_threshold | 1.23162159 |
| 67 | MP0001188_hyperpigmentation | 1.22889861 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.22121472 |
| 69 | MP0001819_abnormal_immune_cell | 1.22088395 |
| 70 | MP0004381_abnormal_hair_follicle | 1.21846650 |
| 71 | MP0002882_abnormal_neuron_morphology | 1.20963608 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.20755513 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.20445597 |
| 74 | MP0002398_abnormal_bone_marrow | 1.19737333 |
| 75 | MP0003631_nervous_system_phenotype | 1.19208748 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.16526758 |
| 77 | MP0005671_abnormal_response_to | 1.15891846 |
| 78 | MP0001835_abnormal_antigen_presentation | 1.14078988 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.11867437 |
| 80 | MP0003690_abnormal_glial_cell | 1.11823893 |
| 81 | MP0002557_abnormal_social/conspecific_i | 1.11386339 |
| 82 | MP0004484_altered_response_of | 1.07669385 |
| 83 | MP0002060_abnormal_skin_morphology | 1.07251634 |
| 84 | MP0003436_decreased_susceptibility_to | 1.06874419 |
| 85 | MP0004510_myositis | 1.05020234 |
| 86 | MP0002229_neurodegeneration | 1.04388676 |
| 87 | MP0000579_abnormal_nail_morphology | 1.02586867 |
| 88 | MP0005535_abnormal_body_temperature | 1.02414600 |
| 89 | MP0005076_abnormal_cell_differentiation | 1.00968175 |
| 90 | MP0003866_abnormal_defecation | 1.00570052 |
| 91 | MP0004130_abnormal_muscle_cell | 1.00396152 |
| 92 | MP0004811_abnormal_neuron_physiology | 1.00319640 |
| 93 | MP0003879_abnormal_hair_cell | 0.98674289 |
| 94 | MP0000716_abnormal_immune_system | 0.98546555 |
| 95 | MP0000955_abnormal_spinal_cord | 0.98061243 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.97608419 |
| 97 | MP0003329_amyloid_beta_deposits | 0.96773816 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.91076021 |
| 99 | MP0002184_abnormal_innervation | 0.90888270 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.90336123 |
| 101 | MP0009931_abnormal_skin_appearance | 0.90319256 |
| 102 | MP0000383_abnormal_hair_follicle | 0.90056207 |
| 103 | MP0008874_decreased_physiological_sensi | 0.90021756 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.89486937 |
| 105 | MP0000371_diluted_coat_color | 0.87781909 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.86235276 |
| 107 | MP0001905_abnormal_dopamine_level | 0.86134710 |
| 108 | MP0002722_abnormal_immune_system | 0.85151510 |
| 109 | MP0004043_abnormal_pH_regulation | 0.84524686 |
| 110 | MP0004885_abnormal_endolymph | 0.84248694 |
| 111 | MP0000689_abnormal_spleen_morphology | 0.84187406 |
| 112 | MP0002909_abnormal_adrenal_gland | 0.83949858 |
| 113 | MP0008872_abnormal_physiological_respon | 0.83899415 |
| 114 | MP0009333_abnormal_splenocyte_physiolog | 0.80591893 |
| 115 | MP0005394_taste/olfaction_phenotype | 0.78777344 |
| 116 | MP0005499_abnormal_olfactory_system | 0.78777344 |
| 117 | MP0002152_abnormal_brain_morphology | 0.77707843 |
| 118 | MP0005310_abnormal_salivary_gland | 0.76821685 |
| 119 | MP0001873_stomach_inflammation | 0.76496549 |
| 120 | MP0000465_gastrointestinal_hemorrhage | 0.76444172 |
| 121 | MP0003123_paternal_imprinting | 0.76189419 |
| 122 | MP0000367_abnormal_coat/_hair | 0.75923027 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.75370358 |
| 124 | MP0001191_abnormal_skin_condition | 0.75304188 |
| 125 | MP0000604_amyloidosis | 0.75235430 |
| 126 | MP0000920_abnormal_myelination | 0.74564589 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.74078562 |
| 128 | MP0000377_abnormal_hair_follicle | 0.72872478 |
| 129 | MP0000647_abnormal_sebaceous_gland | 0.72473792 |
| 130 | MP0000778_abnormal_nervous_system | 0.72341966 |
| 131 | MP0003632_abnormal_nervous_system | 0.64942606 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.62785075 |
| 133 | MP0001177_atelectasis | 0.62485531 |
| 134 | MP0008260_abnormal_autophagy | 0.60986904 |
| 135 | MP0002102_abnormal_ear_morphology | 0.59419372 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.57652630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 5.11552371 |
| 2 | Papilloma (HP:0012740) | 4.72043133 |
| 3 | Verrucae (HP:0200043) | 4.72043133 |
| 4 | Conjunctival hamartoma (HP:0100780) | 4.30943036 |
| 5 | Fair hair (HP:0002286) | 4.04142976 |
| 6 | Abnormality of B cell number (HP:0010975) | 3.96936163 |
| 7 | B lymphocytopenia (HP:0010976) | 3.96936163 |
| 8 | Agammaglobulinemia (HP:0004432) | 3.89526990 |
| 9 | Focal motor seizures (HP:0011153) | 3.83171867 |
| 10 | Abnormality of alanine metabolism (HP:0010916) | 3.78021784 |
| 11 | Hyperalaninemia (HP:0003348) | 3.78021784 |
| 12 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.78021784 |
| 13 | Erythroderma (HP:0001019) | 3.72340422 |
| 14 | Abnormal hair whorl (HP:0010721) | 3.70573475 |
| 15 | Thyroiditis (HP:0100646) | 3.57370563 |
| 16 | Generalized hypopigmentation of hair (HP:0011358) | 3.56059096 |
| 17 | Chronic sinusitis (HP:0011109) | 3.53249912 |
| 18 | Hamartoma of the eye (HP:0010568) | 3.51262124 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.40681213 |
| 20 | Palmoplantar hyperkeratosis (HP:0000972) | 3.31948843 |
| 21 | Action tremor (HP:0002345) | 3.28006185 |
| 22 | Cellulitis (HP:0100658) | 3.21661616 |
| 23 | Spastic gait (HP:0002064) | 3.14484861 |
| 24 | Ankle clonus (HP:0011448) | 3.11473428 |
| 25 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.07931198 |
| 26 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.07931198 |
| 27 | Plantar hyperkeratosis (HP:0007556) | 3.05977760 |
| 28 | Hemiplegia (HP:0002301) | 3.05622634 |
| 29 | Palmar hyperkeratosis (HP:0010765) | 3.02568094 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 3.01450286 |
| 31 | Erythema (HP:0010783) | 2.98152793 |
| 32 | Recurrent viral infections (HP:0004429) | 2.97032546 |
| 33 | Abnormality of the corticospinal tract (HP:0002492) | 2.96728544 |
| 34 | Focal seizures (HP:0007359) | 2.93223307 |
| 35 | Oligodactyly (hands) (HP:0001180) | 2.93179660 |
| 36 | Mild short stature (HP:0003502) | 2.93163328 |
| 37 | Hyperventilation (HP:0002883) | 2.85373639 |
| 38 | Sepsis (HP:0100806) | 2.82044451 |
| 39 | Atonic seizures (HP:0010819) | 2.79615900 |
| 40 | Genetic anticipation (HP:0003743) | 2.78740207 |
| 41 | Lower limb muscle weakness (HP:0007340) | 2.78555340 |
| 42 | Myokymia (HP:0002411) | 2.76968562 |
| 43 | Chronic otitis media (HP:0000389) | 2.76881175 |
| 44 | T lymphocytopenia (HP:0005403) | 2.76217828 |
| 45 | Abnormality of nail color (HP:0100643) | 2.70519695 |
| 46 | Limb dystonia (HP:0002451) | 2.69907810 |
| 47 | Poor eye contact (HP:0000817) | 2.69648899 |
| 48 | Abnormality of T cell number (HP:0011839) | 2.67330619 |
| 49 | Vertebral arch anomaly (HP:0008438) | 2.62495769 |
| 50 | Impaired vibratory sensation (HP:0002495) | 2.61806578 |
| 51 | Hypotrichosis (HP:0001006) | 2.61791756 |
| 52 | Absence seizures (HP:0002121) | 2.59715836 |
| 53 | Meningitis (HP:0001287) | 2.57233217 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.56007722 |
| 55 | Hyperthyroidism (HP:0000836) | 2.48383906 |
| 56 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.47406725 |
| 57 | Status epilepticus (HP:0002133) | 2.44552216 |
| 58 | Recurrent bronchitis (HP:0002837) | 2.43680145 |
| 59 | Failure to thrive in infancy (HP:0001531) | 2.43244348 |
| 60 | Epileptiform EEG discharges (HP:0011182) | 2.43024321 |
| 61 | Polyphagia (HP:0002591) | 2.40212849 |
| 62 | Papilledema (HP:0001085) | 2.38416323 |
| 63 | Severe combined immunodeficiency (HP:0004430) | 2.38101592 |
| 64 | Tetraparesis (HP:0002273) | 2.37663281 |
| 65 | Abnormality of T cells (HP:0002843) | 2.37294316 |
| 66 | Increased circulating renin level (HP:0000848) | 2.34326035 |
| 67 | Supranuclear gaze palsy (HP:0000605) | 2.30070885 |
| 68 | Colitis (HP:0002583) | 2.30006188 |
| 69 | Lip pit (HP:0100267) | 2.29500432 |
| 70 | Febrile seizures (HP:0002373) | 2.28957712 |
| 71 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.27858587 |
| 72 | Blue irides (HP:0000635) | 2.27558166 |
| 73 | Epileptic encephalopathy (HP:0200134) | 2.25377156 |
| 74 | Alacrima (HP:0000522) | 2.24763040 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.24668925 |
| 76 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.24526473 |
| 77 | Impaired smooth pursuit (HP:0007772) | 2.23855149 |
| 78 | Sleep apnea (HP:0010535) | 2.23514877 |
| 79 | Visual hallucinations (HP:0002367) | 2.19593873 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.19140807 |
| 81 | Abnormality of the labia minora (HP:0012880) | 2.18675321 |
| 82 | Slow saccadic eye movements (HP:0000514) | 2.18428117 |
| 83 | Woolly hair (HP:0002224) | 2.17862955 |
| 84 | Sparse scalp hair (HP:0002209) | 2.17824567 |
| 85 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17618850 |
| 86 | Abnormal eating behavior (HP:0100738) | 2.17451097 |
| 87 | Hypoplasia of the thymus (HP:0000778) | 2.16709384 |
| 88 | Encephalitis (HP:0002383) | 2.16484354 |
| 89 | Ocular albinism (HP:0001107) | 2.14910169 |
| 90 | Volvulus (HP:0002580) | 2.14544665 |
| 91 | Thick nail (HP:0001805) | 2.14234683 |
| 92 | Dialeptic seizures (HP:0011146) | 2.14028224 |
| 93 | Bradykinesia (HP:0002067) | 2.13469804 |
| 94 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.13296355 |
| 95 | Hypoplastic nipples (HP:0002557) | 2.12895022 |
| 96 | Recurrent sinusitis (HP:0011108) | 2.12136258 |
| 97 | Generalized tonic-clonic seizures (HP:0002069) | 2.11938729 |
| 98 | Broad-based gait (HP:0002136) | 2.11820010 |
| 99 | Hypsarrhythmia (HP:0002521) | 2.11424151 |
| 100 | Macroorchidism (HP:0000053) | 2.10137759 |
| 101 | Eosinophilia (HP:0001880) | 2.09780953 |
| 102 | Gangrene (HP:0100758) | 2.09636548 |
| 103 | Abnormal social behavior (HP:0012433) | 2.09460436 |
| 104 | Impaired social interactions (HP:0000735) | 2.09460436 |
| 105 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.09446303 |
| 106 | Subaortic stenosis (HP:0001682) | 2.09446303 |
| 107 | Peripheral hypomyelination (HP:0007182) | 2.07482406 |
| 108 | Recurrent cutaneous fungal infections (HP:0011370) | 2.07140362 |
| 109 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.07140362 |
| 110 | Eczematoid dermatitis (HP:0000976) | 2.04695862 |
| 111 | Milia (HP:0001056) | 2.04376697 |
| 112 | Glucose intolerance (HP:0000833) | 2.04336559 |
| 113 | Gastrointestinal stroma tumor (HP:0100723) | 2.03491394 |
| 114 | Dysautonomia (HP:0002459) | 2.02929413 |
| 115 | Aqueductal stenosis (HP:0002410) | 2.02922077 |
| 116 | Truncal ataxia (HP:0002078) | 2.02801564 |
| 117 | Iris hypopigmentation (HP:0007730) | 2.02761075 |
| 118 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01842918 |
| 119 | Clonus (HP:0002169) | 2.00587820 |
| 120 | Progressive inability to walk (HP:0002505) | 2.00146875 |
| 121 | Spinal canal stenosis (HP:0003416) | 1.99700466 |
| 122 | Urinary urgency (HP:0000012) | 1.98332332 |
| 123 | Ankyloglossia (HP:0010296) | 1.97599923 |
| 124 | Delusions (HP:0000746) | 1.97362639 |
| 125 | Neuronal loss in central nervous system (HP:0002529) | 1.96290301 |
| 126 | Stomatitis (HP:0010280) | 1.95557906 |
| 127 | Combined immunodeficiency (HP:0005387) | 1.95446867 |
| 128 | Decreased lacrimation (HP:0000633) | 1.93017313 |
| 129 | Small epiphyses (HP:0010585) | 1.92232353 |
| 130 | Mediastinal lymphadenopathy (HP:0100721) | 1.91592635 |
| 131 | Generalized hypotonia (HP:0001290) | 1.90983342 |
| 132 | Lower limb amyotrophy (HP:0007210) | 1.90869633 |
| 133 | Postural instability (HP:0002172) | 1.88480125 |
| 134 | Resting tremor (HP:0002322) | 1.86910565 |
| 135 | Progressive cerebellar ataxia (HP:0002073) | 1.85510773 |
| 136 | Dysmetric saccades (HP:0000641) | 1.85249409 |
| 137 | Open mouth (HP:0000194) | 1.84908329 |
| 138 | Amyotrophic lateral sclerosis (HP:0007354) | 1.84240131 |
| 139 | Ectropion (HP:0000656) | 1.83885142 |
| 140 | Mutism (HP:0002300) | 1.83791276 |
| 141 | Anxiety (HP:0000739) | 1.83192830 |
| 142 | Obstructive lung disease (HP:0006536) | 1.81511094 |
| 143 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81511094 |
| 144 | IgG deficiency (HP:0004315) | 1.81022509 |
| 145 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.80931752 |
| 146 | Abnormality of oral frenula (HP:0000190) | 1.80514261 |
| 147 | Paraplegia (HP:0010550) | 1.80314256 |
| 148 | Bowel incontinence (HP:0002607) | 1.79403794 |
| 149 | Excessive salivation (HP:0003781) | 1.78728601 |
| 150 | Drooling (HP:0002307) | 1.78728601 |
| 151 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78404111 |
| 152 | Spastic paraplegia (HP:0001258) | 1.78324332 |
| 153 | Truncal obesity (HP:0001956) | 1.77584868 |
| 154 | Ventricular fibrillation (HP:0001663) | 1.76880377 |
| 155 | Widely spaced teeth (HP:0000687) | 1.76274539 |
| 156 | Depression (HP:0000716) | 1.75949745 |
| 157 | Stereotypic behavior (HP:0000733) | 1.75904486 |
| 158 | Absent speech (HP:0001344) | 1.75902634 |
| 159 | Hemiparesis (HP:0001269) | 1.75793755 |
| 160 | Hamartoma (HP:0010566) | 1.75560599 |
| 161 | Abnormality of binocular vision (HP:0011514) | 1.75318040 |
| 162 | Diplopia (HP:0000651) | 1.75318040 |
| 163 | Abnormality of the fingertips (HP:0001211) | 1.75001214 |
| 164 | Osteomyelitis (HP:0002754) | 1.74971848 |
| 165 | Thyroid-stimulating hormone excess (HP:0002925) | 1.74683776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 3.89489868 |
| 2 | MAP3K9 | 3.88023545 |
| 3 | RIPK4 | 3.04453589 |
| 4 | SIK2 | 3.00542650 |
| 5 | NTRK3 | 2.96165909 |
| 6 | NTRK2 | 2.69345893 |
| 7 | GRK6 | 2.39061252 |
| 8 | MAP3K13 | 2.34844817 |
| 9 | CAMK4 | 2.21071569 |
| 10 | SIK3 | 2.13043258 |
| 11 | MAP4K1 | 2.12718232 |
| 12 | STK39 | 2.10731319 |
| 13 | MAP3K4 | 2.09634850 |
| 14 | WNK4 | 2.07325790 |
| 15 | SYK | 1.87224215 |
| 16 | EEF2K | 1.84602882 |
| 17 | EPHA4 | 1.83114056 |
| 18 | FES | 1.79288489 |
| 19 | CAMKK2 | 1.77550126 |
| 20 | KSR2 | 1.67431230 |
| 21 | BLK | 1.58943981 |
| 22 | TAOK3 | 1.58343177 |
| 23 | PIK3CG | 1.55838159 |
| 24 | SCYL2 | 1.55222585 |
| 25 | WNK1 | 1.45192110 |
| 26 | OXSR1 | 1.44285362 |
| 27 | GRK5 | 1.38029133 |
| 28 | TNK2 | 1.36434055 |
| 29 | MAP2K7 | 1.33369380 |
| 30 | KSR1 | 1.32977397 |
| 31 | MINK1 | 1.31482304 |
| 32 | TAOK1 | 1.30905314 |
| 33 | ITK | 1.29314407 |
| 34 | MAP3K12 | 1.21388994 |
| 35 | ERBB3 | 1.20966893 |
| 36 | ZAP70 | 1.20894858 |
| 37 | CASK | 1.20085638 |
| 38 | HCK | 1.19829556 |
| 39 | MARK1 | 1.18919975 |
| 40 | MAP4K2 | 1.16572347 |
| 41 | MARK2 | 1.16474622 |
| 42 | PINK1 | 1.14395929 |
| 43 | ERN1 | 1.13763393 |
| 44 | MAP2K4 | 1.13362323 |
| 45 | CAMK2A | 1.10188609 |
| 46 | MAP3K2 | 1.08088379 |
| 47 | MAP3K7 | 1.03353931 |
| 48 | DAPK2 | 1.00993268 |
| 49 | TRPM7 | 0.99932481 |
| 50 | PAK6 | 0.97414530 |
| 51 | CDK5 | 0.97347997 |
| 52 | CAMK2B | 0.96291532 |
| 53 | SGK3 | 0.96158657 |
| 54 | DYRK3 | 0.95510494 |
| 55 | FGFR3 | 0.95480333 |
| 56 | MARK3 | 0.94797123 |
| 57 | FGFR2 | 0.94750030 |
| 58 | PKN2 | 0.90359330 |
| 59 | ARAF | 0.90345748 |
| 60 | PRKCH | 0.89850461 |
| 61 | SGK2 | 0.88276148 |
| 62 | CCNB1 | 0.88092512 |
| 63 | MAP3K11 | 0.88055840 |
| 64 | MST4 | 0.87696324 |
| 65 | TNIK | 0.86974497 |
| 66 | TRIB3 | 0.85892692 |
| 67 | EPHA3 | 0.85847565 |
| 68 | BTK | 0.82672303 |
| 69 | ALK | 0.82584780 |
| 70 | BCR | 0.80360812 |
| 71 | MAP3K1 | 0.79947494 |
| 72 | BUB1 | 0.78681046 |
| 73 | FGR | 0.78547290 |
| 74 | MAPK13 | 0.77966424 |
| 75 | PDK1 | 0.76772290 |
| 76 | TXK | 0.75973846 |
| 77 | TYRO3 | 0.75883902 |
| 78 | CDK12 | 0.74606655 |
| 79 | FYN | 0.72441714 |
| 80 | SGK1 | 0.72389883 |
| 81 | MAP3K5 | 0.72346003 |
| 82 | MAP3K14 | 0.70962866 |
| 83 | RAF1 | 0.70684234 |
| 84 | JAK2 | 0.68337394 |
| 85 | SGK494 | 0.68215134 |
| 86 | SGK223 | 0.68215134 |
| 87 | STK11 | 0.67531508 |
| 88 | PRKCQ | 0.66983857 |
| 89 | MAPKAPK3 | 0.66664661 |
| 90 | LCK | 0.66535192 |
| 91 | MAPK12 | 0.66216932 |
| 92 | CSK | 0.64561617 |
| 93 | STK10 | 0.63499833 |
| 94 | UHMK1 | 0.61942023 |
| 95 | CAMK1G | 0.61078158 |
| 96 | PRKCZ | 0.60568190 |
| 97 | RET | 0.59768559 |
| 98 | FRK | 0.59398249 |
| 99 | MAPK10 | 0.59124068 |
| 100 | JAK1 | 0.57202580 |
| 101 | CSNK1A1L | 0.56964088 |
| 102 | RPS6KA2 | 0.54684497 |
| 103 | CSNK1G2 | 0.53849563 |
| 104 | CAMK1 | 0.52519492 |
| 105 | PKN1 | 0.52507464 |
| 106 | TLK1 | 0.51457297 |
| 107 | WNK3 | 0.51285597 |
| 108 | CDK19 | 0.50484081 |
| 109 | TEC | 0.49423841 |
| 110 | PRKCG | 0.48970208 |
| 111 | CDK14 | 0.48481610 |
| 112 | CAMKK1 | 0.48360774 |
| 113 | DYRK1A | 0.48124511 |
| 114 | LRRK2 | 0.48052792 |
| 115 | CDK18 | 0.47685862 |
| 116 | MAPK7 | 0.47556591 |
| 117 | BRAF | 0.46930346 |
| 118 | DYRK1B | 0.46803653 |
| 119 | PDPK1 | 0.46273178 |
| 120 | LYN | 0.45006091 |
| 121 | MAPK4 | 0.44986168 |
| 122 | PLK2 | 0.44984763 |
| 123 | BMPR2 | 0.44585307 |
| 124 | TSSK6 | 0.43706443 |
| 125 | JAK3 | 0.43234624 |
| 126 | EPHB1 | 0.42156261 |
| 127 | CDK15 | 0.41158167 |
| 128 | TYK2 | 0.40438280 |
| 129 | CAMK2G | 0.39511935 |
| 130 | HIPK2 | 0.38866368 |
| 131 | IKBKE | 0.37994567 |
| 132 | EGFR | 0.37479441 |
| 133 | MAP2K6 | 0.36950317 |
| 134 | PAK3 | 0.36425333 |
| 135 | RPS6KA3 | 0.36028364 |
| 136 | DAPK1 | 0.35796633 |
| 137 | CSNK1D | 0.35660125 |
| 138 | CSNK1G3 | 0.35339125 |
| 139 | PRKD3 | 0.35176583 |
| 140 | ERBB2 | 0.34763045 |
| 141 | PTK2B | 0.34715644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.53900781 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.35418922 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.34947779 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.27436656 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.13017908 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.11934120 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.10814374 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.85262665 |
| 9 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82371656 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.81716706 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.78322303 |
| 12 | Renin secretion_Homo sapiens_hsa04924 | 1.64342617 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.62880538 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57937954 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.56188567 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.51825972 |
| 17 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.48802744 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48482971 |
| 19 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.47316356 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46873621 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44655511 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.41485656 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.41368485 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38948981 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37941142 |
| 26 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.37603734 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.36076758 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.31143872 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30143093 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30007750 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28172986 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28022475 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.25364681 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.23064484 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22984610 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21363704 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.20449173 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.20408187 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.19333876 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15979674 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13951999 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12247248 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10460351 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09610857 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09395817 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08679083 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04154159 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 1.02677248 |
| 49 | Alcoholism_Homo sapiens_hsa05034 | 1.01261199 |
| 50 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.99061068 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98972395 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91758938 |
| 53 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90859189 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90233380 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.88560580 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88138629 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87464561 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86770626 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 0.86691532 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85773504 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85257286 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84700018 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83246403 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82996937 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80392909 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80388334 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79908765 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.78527655 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76732515 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.76249154 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75010023 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.74349767 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73553260 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71550920 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70500902 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70338048 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70174584 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67690100 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66000159 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65770248 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64530519 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63670988 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62043205 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.61937327 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61826179 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60923658 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60690104 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60298088 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60104012 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57574243 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.55932254 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55446350 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55159726 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53746068 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53657595 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53624334 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53351577 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53027286 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51771531 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51365215 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50664966 |
| 102 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50627364 |
| 103 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50023203 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49600435 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.48424116 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48211198 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45630700 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45630385 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45330124 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45259556 |
| 111 | Measles_Homo sapiens_hsa05162 | 0.44574473 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44342162 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41165979 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39746994 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39484739 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35469554 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34844827 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33120594 |

